Compare Nerdwallet Inc (NRDS) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nerdwallet Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Nerdwallet Inc trades at $9.55 (market cap $616.22M), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 17.5× Nerdwallet Inc's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Nerdwallet Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nerdwallet Inc for 45 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| NRDS | RDY | |
|---|---|---|
Market Cap | $616.22M | $10.78B |
Volume | 640,272 | 2,724,343 |
Sector | Media | Health |
52-Week High | $15.93 | $15.38 |
52-Week Low | $7.58 | $11.38 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $530.52M | $10.68B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRDS trades at $9.55, down 2.75% today, but maintains strong fundamentals with a P/E of 10.71 and P/S of 0.8, indicating potential undervaluation. The company has shown consistent revenue growth from $539M in 2022 to $837M in 2025, with net income turning positive since 2024. Recent Q2 2026 earnings missed expectations at $0.07 per share versus $0.0934 expected, though Q1 and Q4 2025 beat estimates. Technical indicators show a bullish trend with strong moving average signals, though RSI levels suggest potential overbought conditions.
The outlook for NRDS remains positive with analyst consensus at 66.7% buy ratings and projected 27.9% upside potential. Strong profitability metrics include 93.5% gross margins and 18.16% ROE. Key risks include competitive pressures in financial guidance markets and reliance on organic search traffic. The company's improving cash flow from operations ($132M in 2025) supports continued growth initiatives in personal loans and deposit accounts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nerdwallet Inc
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
